Flohale 0.5 mg Respules are associated with fluticasone propionate inhalation therapy. Confirm the exact concentration, respule volume, manufacturer, and locally approved indications before publishing. A label showing 0.5 mg/2 mL is not interchangeable with one showing 0.5 mg/mL.
Flohale Respules are intended for prescribed nebulised anti-inflammatory treatment. They are not rescue medication for sudden asthma attacks and must not replace a fast-acting bronchodilator when immediate relief is required.
What Are Flohale 0.5 mg Respules?
Flohale 0.5 mg Respules contain fluticasone propionate, a corticosteroid used to help control inflammation in the respiratory airways.
Fluticasone propionate belongs to the inhaled corticosteroid class of medicines.
Asthma is a chronic inflammatory condition in which the airways become swollen, sensitive, and prone to narrowing.
This may cause wheezing, coughing, chest tightness, and shortness of breath.
Fluticasone reduces inflammatory signaling within the airways.
By controlling inflammation, it may reduce the frequency of asthma symptoms and exacerbations.
Respules are small, usually single-use containers containing a liquid preparation intended for nebulisation.
A compatible nebuliser converts the liquid into an inhalable mist.
This method may be useful for selected patients who cannot effectively use conventional inhalers or who require nebulised corticosteroid treatment.
However, not every fluticasone formulation is suitable for every nebuliser.
Common Reasons for Prescribing Flohale Respules
- Maintenance treatment of bronchial asthma
- Control of chronic airway inflammation
- Reduction of recurrent wheezing associated with asthma
- Management of persistent asthma symptoms
- Prevention of asthma exacerbations
- Reduction of nighttime asthma symptoms
- Long-term asthma controller treatment
- Nebulised corticosteroid therapy in selected patients
- Reduction of asthma-related coughing
- Support for individualized respiratory treatment plans
Important: Flohale is not an antibiotic, bronchodilator, or immediate treatment for severe breathing difficulty.
How Do Flohale 0.5 mg Respules Work?
1. Deliver Fluticasone to the Airways
The nebuliser converts the prescribed suspension into an aerosol that can be inhaled into the respiratory tract.
2. Activate Glucocorticoid Receptors
Fluticasone binds to intracellular glucocorticoid receptors.
3. Reduce Inflammatory Mediators
The medicine suppresses the production of substances involved in airway inflammation.
4. Reduce Airway Swelling
Fluticasone helps reduce inflammation-related swelling in the bronchial lining.
5. Decrease Airway Hyperresponsiveness
Regular treatment may reduce excessive sensitivity to common asthma triggers.
6. Reduce Inflammatory Cell Activity
Fluticasone suppresses the activity of several inflammatory cells involved in asthma.
7. Support Long-Term Asthma Control
Continued treatment may reduce recurrent asthma symptoms.
8. Reduce Asthma Exacerbation Risk
Effective inhaled corticosteroid therapy can reduce the likelihood of asthma flare-ups.
9. Improve Respiratory Stability
By controlling inflammation, fluticasone may improve long-term symptom management.
10. Provide Local Anti-Inflammatory Action
Nebulised fluticasone acts primarily within the respiratory tract, although systemic absorption can occur.
Important: Fluticasone does not directly relax airway smooth muscle and cannot provide immediate bronchodilation.
Uses of Flohale 0.5 mg Respules
1. Bronchial Asthma
Flohale may be prescribed for asthma maintenance treatment where the formulation is approved and clinically appropriate.
2. Persistent Asthma
It helps control ongoing inflammation associated with persistent asthma.
3. Prevention of Asthma Exacerbations
Regular corticosteroid therapy may reduce the frequency of asthma flare-ups.
4. Asthma-Related Wheezing
It may reduce recurrent wheezing caused by chronic airway inflammation.
5. Asthma-Related Cough
Fluticasone may help control persistent coughing associated with asthma.
6. Nighttime Asthma Symptoms
Effective maintenance treatment may reduce nighttime respiratory symptoms.
7. Airway Inflammation
Flohale suppresses inflammatory activity within the respiratory tract.
8. Airway Hyperresponsiveness
Regular treatment may reduce excessive airway sensitivity to triggers.
9. Long-Term Respiratory Management
It may be included in an ongoing asthma treatment plan.
10. Nebulised Corticosteroid Therapy
The respule formulation provides an alternative delivery method for selected patients.
Important: Do not advertise Flohale 0.5 mg Respules as an approved treatment for COPD, bronchiolitis, pneumonia, or other respiratory conditions unless those indications are supported by the exact local product labeling.
Flohale 0.5 mg Respules Dosage and Administration
The prescribed dose depends on age, asthma severity, previous corticosteroid treatment, clinical response, and the exact product concentration.
General Dosage Information
| Dosage Information | Details |
|---|---|
| Active Ingredient | Fluticasone Propionate |
| Listed Strength | 0.5 mg |
| Strength Equivalent | 500 mcg |
| Dosage Form | Nebuliser Suspension |
| Administration Route | Oral Inhalation by Nebuliser |
| Dose per Session | As prescribed |
| Frequency | Determined by the prescriber |
| Treatment Duration | Based on clinical assessment |
| Nebuliser Type | Compatible device specified in the product instructions |
| Emergency Asthma Relief | Not suitable |
| Medical Supervision | Required |
Important: The listed strength alone does not establish the prescribed dose or number of respules to use.
How to Use Flohale 0.5 mg Respules
- Wash your hands before handling the medicine.
- Confirm the product name and concentration.
- Check the expiry date.
- Inspect the respule for damage.
- Prepare the compatible nebuliser according to its instructions.
- Gently resuspend the medicine if directed by the manufacturer.
- Open the respule immediately before use.
- Empty the prescribed quantity into the nebuliser chamber.
- Do not mix with other medicines unless compatibility is specifically confirmed.
- Attach the appropriate mouthpiece or face mask.
- Sit upright during treatment.
- Switch on the nebuliser.
- Breathe normally through the mouthpiece or mask.
- Continue until the prescribed treatment is complete.
- Switch off the nebuliser.
- Discard any remaining medicine as directed by the product instructions.
- Rinse your mouth with water and spit it out.
- If a face mask was used, wash the face afterward.
- Clean and dry the nebuliser components according to the manufacturer’s instructions.
- Store unopened respules according to the product label.
Can Flohale Respules Be Used Every Day?
Yes, when prescribed as regular maintenance treatment.
Consistent use is important for controlling airway inflammation.
Can Flohale Respules Be Used During an Asthma Attack?
No.
Fluticasone is not a fast-acting bronchodilator.
Patients should follow their prescribed asthma action plan and use the appropriate rescue medication.
Can Flohale Respules Be Mixed With Other Nebuliser Medicines?
Only when the manufacturer or healthcare professional confirms compatibility.
Do not automatically mix Flohale with salbutamol, levosalbutamol, ipratropium, or other nebuliser solutions.
What If a Dose Is Missed?
Use the missed dose when remembered unless it is nearly time for the next scheduled dose.
Do not double the dose.
Can Flohale Be Stopped Suddenly?
Do not independently discontinue regular asthma controller therapy.
Stopping treatment may worsen asthma control.
Patients transitioning from oral corticosteroids may require additional supervision.
How Long Do Flohale 0.5 mg Respules Take to Work?
Fluticasone begins reducing inflammatory activity after inhalation.
However, it does not provide immediate symptom relief.
Some patients may notice improvement within several days.
More consistent asthma control may take one to several weeks.
Treatment response depends on asthma severity, correct nebuliser use, and adherence to the prescribed regimen.
Common Side Effects
Possible side effects include:
- Oral thrush
- Hoarseness
- Throat irritation
- Sore throat
- Coughing after nebulisation
- Dry mouth
- Unpleasant taste
- Voice changes
- Headache
- Mild respiratory irritation
- Facial skin irritation when using a mask
Rinsing the mouth and spitting out the water after treatment can help reduce the risk of oral candidiasis.
Potentially Harmful Effects & Serious Health Risks
1. Oral Candidiasis
Fluticasone may increase the risk of fungal infection in the mouth and throat.
2. Hoarseness
Inhaled corticosteroids may cause voice changes.
3. Paradoxical Bronchospasm
Rarely, inhalation may cause sudden worsening of wheezing or breathing difficulty.
4. Adrenal Suppression
High-dose or prolonged corticosteroid exposure may suppress adrenal hormone production.
5. Growth Effects in Children
Long-term inhaled corticosteroid therapy may reduce growth velocity in some children.
6. Reduced Bone Mineral Density
Prolonged corticosteroid exposure may affect bone health.
7. Osteoporosis
Patients with additional risk factors may be more susceptible to bone loss.
8. Cataracts
Long-term corticosteroid exposure may increase cataract risk.
9. Glaucoma
Inhaled corticosteroids may contribute to increased intraocular pressure in susceptible patients.
10. Increased Susceptibility to Infections
Corticosteroid therapy can influence immune responses.
11. Systemic Corticosteroid Effects
High systemic exposure may occasionally cause Cushingoid features and other corticosteroid complications.
12. Serious Allergic Reactions
Rare hypersensitivity reactions may occur.
13. Drug Interaction-Related Toxicity
Strong CYP3A4 inhibitors can increase systemic fluticasone exposure.
14. Inadequate Medicine Delivery
Incorrect nebuliser use may reduce the amount of medicine reaching the lungs.
15. Poor Asthma Control
Failure to follow the prescribed maintenance regimen may increase the risk of exacerbations.
Emergency warning: Seek immediate medical attention for severe breathing difficulty, sudden worsening of wheezing after nebulisation, facial or throat swelling, or signs of a serious allergic reaction.
Contraindications & Safety Precautions
1. Hypersensitivity to Fluticasone
Do not use the medicine if allergic to fluticasone propionate or any formulation ingredient.
2. Acute Asthma Attacks
Flohale is not suitable as the sole treatment for acute asthma symptoms.
3. Status Asthmaticus
Life-threatening asthma requires emergency medical treatment.
4. Respiratory Infections
Patients with active respiratory infections may require additional assessment.
5. Tuberculosis
Patients with active or previous tuberculosis should inform their healthcare professional.
6. Fungal Infections
Inhaled corticosteroids may increase the risk of local fungal infections.
7. Oral Thrush
Patients developing oral candidiasis may require antifungal treatment and review of administration technique.
8. Adrenal Disorders
Patients with adrenal suppression or previous systemic corticosteroid exposure may require monitoring.
9. Liver Disease
Significant liver impairment may increase systemic corticosteroid exposure.
10. Osteoporosis
Patients with reduced bone density may require additional assessment during prolonged treatment.
11. Glaucoma and Cataracts
Patients with eye disorders should report visual changes.
12. Pregnancy
Maintaining adequate asthma control during pregnancy is important.
Fluticasone may be used when clinically appropriate following medical assessment.
13. Breastfeeding
Inhaled fluticasone is generally considered compatible with breastfeeding at recommended doses, although individual assessment is appropriate.
14. Children
Pediatric use depends on the approved age range, formulation, and prescribed dose.
Growth should be monitored during long-term treatment.
15. Older Adults
Older patients may require additional monitoring for bone health and eye complications.
16. Nebuliser Compatibility
Use only a compatible nebuliser as specified in the product instructions.
17. Drug Interactions
Potentially important interactions include:
- Ritonavir: May substantially increase systemic fluticasone exposure.
- Cobicistat-Containing Medicines: May increase the risk of systemic corticosteroid effects.
- Ketoconazole: May increase fluticasone concentrations.
- Itraconazole: May increase systemic corticosteroid exposure.
- Other Strong CYP3A4 Inhibitors: May increase the risk of adrenal suppression and other systemic effects.
- Other Corticosteroids: May increase cumulative corticosteroid exposure.
18. Correct Nebulisation Technique
Incorrect administration may reduce treatment effectiveness.
19. Nebuliser Hygiene
Poorly maintained equipment may increase the risk of contamination.
20. Medical Monitoring
Healthcare professionals may monitor:
- Asthma symptom frequency
- Nighttime symptoms
- Rescue inhaler use
- Lung function
- Asthma exacerbations
- Nebuliser technique
- Oral thrush
- Hoarseness
- Growth in children
- Bone health when indicated
- Eye symptoms
- Adrenal function when clinically indicated
- Treatment adherence
- Need for dose adjustment
Advantages
- Inhaled corticosteroid therapy.
- Direct delivery to the respiratory airways.
- Helps control airway inflammation.
- Supports long-term asthma management.
- May reduce recurrent asthma symptoms.
- May reduce nighttime asthma symptoms.
- May prevent asthma exacerbations.
- May improve overall asthma control.
- May reduce reliance on rescue bronchodilators.
- Nebuliser-based delivery.
- Established anti-inflammatory mechanism.
- Suitable for selected patients requiring nebulised therapy.
- Supports individualized maintenance treatment.
Disadvantages / Limitations
- Does not provide immediate asthma relief.
- Requires compatible nebuliser equipment.
- Requires correct nebulisation technique.
- May cause oral thrush.
- May cause hoarseness.
- May cause throat irritation.
- May cause coughing after inhalation.
- May cause paradoxical bronchospasm.
- High-dose exposure may cause adrenal suppression.
- Long-term use may affect growth velocity in children.
- Long-term exposure may affect bone health.
- May increase cataract or glaucoma risk.
- May interact with strong CYP3A4 inhibitors.
- Requires regular treatment adherence.
- May require monitoring during prolonged treatment.
- Does not cure asthma permanently.
- Cannot replace emergency reliever treatment.
- Exact concentration and device compatibility must be verified.
Important Notes
Generic Name: Fluticasone Propionate.
Product Name: Flohale 0.5 mg Respules.
Listed Strength: 0.5 mg (500 mcg).
Drug Class: Inhaled Corticosteroid.
Therapeutic Category: Respiratory Medicine / Asthma Controller.
Primary Use: Maintenance treatment of bronchial asthma.
Mechanism: Suppression of inflammatory activity in the airways.
Administration Route: Inhalation by Nebuliser.
Dosage Form: Nebuliser Suspension.
Major Warning: Not suitable for immediate relief during an acute asthma attack.
Common Side Effects: Oral thrush, hoarseness, and throat irritation.
Serious Risks: Adrenal suppression, paradoxical bronchospasm, and systemic corticosteroid effects.
Pregnancy: Use according to medical assessment.
Breastfeeding: Generally compatible at recommended inhaled doses.
Pediatric Use: Follow age-specific product labeling.
Monitoring: Asthma control, nebuliser technique, oral health, and systemic corticosteroid effects when indicated.
Prescription Status: Prescription Medicine.
Storage: Follow manufacturer instructions.
Frequently Asked Questions
1. What are Flohale 0.5 mg Respules used for?
Flohale Respules may be used for maintenance treatment of bronchial asthma when nebulised fluticasone is clinically appropriate.
2. What is the generic name of Flohale Respules?
The generic name is fluticasone propionate.
3. Is Flohale a steroid medicine?
Yes. Fluticasone propionate is an inhaled corticosteroid.
4. How do Flohale Respules work?
They reduce inflammatory activity in the respiratory airways, helping control asthma symptoms over time.
5. Can Flohale provide immediate asthma relief?
No. Flohale is a controller medicine and does not provide rapid bronchodilation.
6. Can Flohale help reduce wheezing?
Yes. Regular treatment may reduce wheezing associated with asthma-related inflammation.
7. Can Flohale help with asthma-related coughing?
Yes. It may help control coughing caused by persistent airway inflammation.
8. Can Flohale Respules be used daily?
Yes, when prescribed for regular maintenance treatment.
9. Can Flohale prevent asthma attacks?
Regular inhaled corticosteroid treatment may reduce asthma exacerbation risk but cannot eliminate it completely.
10. Can Flohale cause oral thrush?
Yes. Oral candidiasis is a recognized side effect.



































































Reviews
There are no reviews yet.